首页> 外国专利> (20R) and (20S)-24-(p-toluenesulfonyloxy)-25,26,27-trinorvitamin D3 analogs and their uses

(20R) and (20S)-24-(p-toluenesulfonyloxy)-25,26,27-trinorvitamin D3 analogs and their uses

机译:(20R)和(20S)-24-( p -甲苯磺酰氧基)-25,26,27-trinorvitamin D 3 类似物及其用途

摘要

This invention discloses (20R) and (20S)-24-(p-toluenesulfonyloxy)-25,26,27-trinorvitamin D3 analogs, and especially (20R)-25,26,27-trinor-24-(p-methylphenylsulfonate)-vitamin D3, its biological activities, and pharmaceutical uses therefor. This compound exhibits relatively little calcemic activity and does not promote cellular differentiation of HL-60 leukemia cells, but rather kills the cells. This cell death activity is found in small cell lung carcinoma also, but not in prostate, bone or ovarian cancer cells. This compound thus causes specific cell death in the absence of changes in calcium levels and without general toxicity in an animal. Therefore it might serve as a useful therapy for treatment of some forms of cancer, such as leukemia and lung cancer.
机译:本发明公开了(20R)和(20S)-24-(对甲苯磺酰氧基)-25,26,27-trinorvitamin D 3 类似物,尤其是(20R)-25,26,27-trinor -24-(对甲基苯基磺酸盐)-维生素D 3 ,其生物学活性及其药物用途。该化合物表现出相对较少的钙减少活性,并且不促进HL-60白血病细胞的细胞分化,而是杀死细胞。在小细胞肺癌中也发现了这种细胞死亡活性,但在前列腺癌,骨癌或卵巢癌细胞中却没有发现。因此,该化合物在钙水平无变化且对动物无一般毒性的情况下引起特异性细胞死亡。因此,它可以作为治疗某些形式的癌症,例如白血病和肺癌的有用疗法。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号